Kirjoita osake tai kryptovaluutta hakupalkkiin saadaksesi yhteenvedon
Medistim ASA
MEDIMedistim ASA develops, produces, services, leases, and distributes medical devices for cardiac and vascular surgery in the United States, Europe, Asia, and internationally. The company offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and TTFM in a single system for vascular surgery; MiraQ Ultimate that combines TTFM and ultrasound imaging in a single system for cardiac, vascular, and transplant surgery; and imaging probes for intraoperative use. It also provides QuickFit TTFM probes, which is designed to hold the vessel and ensure precise measurements on various types of vessel grafts; Vascular TTFM probes for locking slide mechanism designed to secure the vessel while minimizing the manipulation of fragile or calcified vessels; and Doppler probes that are used to search for intramural coronary arteries or to locate the position and quantify the degree of a stenosis. In addition, the company distributes and sells third party medical equipment. Medistim ASA was founded in 1984 and is headquartered in Oslo, Norway. Address: Oekernveien 94, Oslo, Norway, 0579
Analytics
WallStreetin tavoitehinta
1 916.75 NOKP/E-suhde
24.0072Osinkotuotto
3.41 %Kuluva vuosi
Edellinen vuosi
Nykyinen vuosineljännes
Viimeinen vuosineljännes
Kuluva vuosi
Edellinen vuosi
Nykyinen vuosineljännes
Viimeinen vuosineljännes
Avainluvut MEDI
Osinkoanalytiikka MEDI
Osinkojen kasvu 5 vuoden aikana
125 %Jatkuva kasvu
9 vuottaMaksusuhde 5 vuoden keskiarvo
105 %Osinkohistoria MEDI
Osakkeen arvostus MEDI
Talousasiat MEDI
Tuloksia | 2019 | Dynamiikka |